Created at	Source	Raw Value	Validated value
April 14, 2021, 2:05 p.m.	oms	safety; tolerability; pharmacokinetic profile and immunogenicity;AE/SAE;Cmax;AUC0-inf;AUC0-t;Tmax;t1/2;MRT;?z;CL;Vz;Total positive rate of anti-drug antibodies;The positive proportion of anti-drug antibodies at different test times;nutralizing ability of anti-drug antibodies for JMB2002;	safety; tolerability; pharmacokinetic profile and immunogenicity;AE/SAE;Cmax;AUC0-inf;AUC0-t;Tmax;t1/2;MRT;?z;CL;Vz;Total positive rate of anti-drug antibodies;The positive proportion of anti-drug antibodies at different test times;nutralizing ability of anti-drug antibodies for JMB2002;